Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma.
Kim
D H
DH
Baek
J H
JH
Chae
Y S
YS
Kim
Y-K
YK
Kim
H J
HJ
Park
Y H
YH
Song
H S
HS
Chung
J S
JS
Hyun
M S
MS
Sohn
S K
SK
D018951:Antigens, CD20 / Q000096:biosynthesis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000166:cytology*; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D008495:Medical Oncology / Q000379:methods; D015999:Multivariate Analysis; D016017:Odds Ratio; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D018951:Antigens, CD20; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone